269 related articles for article (PubMed ID: 2311658)
1. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
Dourish CT; O'Neill MF; Coughlan J; Kitchener SJ; Hawley D; Iversen SD
Eur J Pharmacol; 1990 Jan; 176(1):35-44. PubMed ID: 2311658
[TBL] [Abstract][Full Text] [Related]
2. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
O'Neill MF; Dourish CT; Iversen SD
Neuropharmacology; 1989 Mar; 28(3):243-7. PubMed ID: 2725851
[TBL] [Abstract][Full Text] [Related]
3. CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.
Xu XJ; Wiesenfeld-Hallin Z; Hughes J; Horwell DC; Hökfelt T
Br J Pharmacol; 1992 Mar; 105(3):591-6. PubMed ID: 1628146
[TBL] [Abstract][Full Text] [Related]
4. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
Lavigne GJ; Millington WR; Mueller GP
Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.
Dourish CT; Hawley D; Iversen SD
Eur J Pharmacol; 1988 Mar; 147(3):469-72. PubMed ID: 3378566
[TBL] [Abstract][Full Text] [Related]
6. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
7. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
8. The role of CCK caerulein, and CCK antagonists in nociception.
Baber NS; Dourish CT; Hill DR
Pain; 1989 Dec; 39(3):307-328. PubMed ID: 2694075
[TBL] [Abstract][Full Text] [Related]
9. The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats.
Kayser V; Idänpään-Hekkilä JJ; Christensen D; Guilbaud G
Life Sci; 1998; 62(10):947-52. PubMed ID: 9496717
[TBL] [Abstract][Full Text] [Related]
10. CCK(B) receptor antagonist L365,260 potentiates the efficacy to and reverses chronic tolerance to electroacupuncture-induced analgesia in mice.
Huang C; Hu ZP; Jiang SZ; Li HT; Han JS; Wan Y
Brain Res Bull; 2007 Mar; 71(5):447-51. PubMed ID: 17259012
[TBL] [Abstract][Full Text] [Related]
11. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
Zhou Y; Sun YH; Han JS
Sheng Li Xue Bao; 1993 Jun; 45(3):255-61. PubMed ID: 8235725
[TBL] [Abstract][Full Text] [Related]
12. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
13. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
Dourish CT; O'Neill MF; Schaffer LW; Siegl PK; Iversen SD
J Pharmacol Exp Ther; 1990 Dec; 255(3):1158-65. PubMed ID: 2262899
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
Panerai AE; Rovati LC; Cocco E; Sacerdote P; Mantegazza P
Brain Res; 1987 Apr; 410(1):52-60. PubMed ID: 3580899
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
Lu L; Huang M; Liu Z; Ma L
Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
[TBL] [Abstract][Full Text] [Related]
16. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice.
Hendrie CA; Shepherd JK; Rodgers RJ
Neuropharmacology; 1989 Oct; 28(10):1025-32. PubMed ID: 2812281
[TBL] [Abstract][Full Text] [Related]
18. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
Hoffmann O; Wiesenfeld-Hallin Z
Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
20. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
Maldonado R; Derrien M; Noble F; Roques BP
Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
